D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 9.92% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Avery Dennison
AVY
$12.9B
| $1.21M | ﹤0.01% |
+9,218
| New | +$1.16M |
|
2802
Methode Electronics
MEI
$525M
| $1.21M | ﹤0.01% |
30,617
-15,325
| -33% | -$556K |
|
2803
PUT
Resideo Technologies
REZI
$5.55B
| $1.2M | ﹤0.01% |
100,700
+50,000
| +99% | +$569K |
|
2804
CALL
Cencora
COR
$62.2B
| $1.2M | ﹤0.01% |
14,100
| – | – |
|
2805
Boston Beer
SAM
$1.93B
| $1.2M | ﹤0.01% |
3,167
-20,287
| -86% | -$7.64M |
|
2806
Cogent Communications
CCOI
$649M
| $1.2M | ﹤0.01% |
18,172
+4,891
| +37% | +$295K |
|
2807
Scorpio Tankers
STNG
$3.94B
| $1.2M | ﹤0.01% |
+30,412
| New | +$1.04M |
|
|
SBBP
2808
DELISTED
Strongbridge Biopharma plc.
SBBP
| $1.2M | ﹤0.01% |
572,225
-327,008
| -36% | -$627K |
|
|
I
2809
CALL
DELISTED
INTELSAT S. A.
I
| $1.2M | ﹤0.01% |
+170,000
| New | +$2.67M |
|
2810
CALL
Enbridge
ENB
$121B
| $1.19M | ﹤0.01% |
+30,000
| New | +$1.12M |
|
|
GBT
2811
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.19M | ﹤0.01% |
15,000
| – | – |
|
2812
PUT
Everest Group
EG
$15.8B
| $1.19M | ﹤0.01% |
4,300
+3,200
| +291% | +$844K |
|
|
LM
2813
DELISTED
Legg Mason, Inc.
LM
| $1.19M | ﹤0.01% |
33,118
+27,756
| +518% | +$1.03M |
|
|
AYX
2814
DELISTED
Alteryx Inc
AYX
| $1.19M | ﹤0.01% |
11,860
-171,855
| -94% | -$17.5M |
|
2815
AGNC Investment
AGNC
$12.9B
| $1.19M | ﹤0.01% |
+67,076
| New | +$1.14M |
|
2816
Liberty Latin America Class C
LILAK
$1.65B
| $1.19M | ﹤0.01% |
71,199
-31,163
| -30% | -$482K |
|
|
WIFI
2817
DELISTED
Boingo Wireless, Inc.
WIFI
| $1.18M | ﹤0.01% |
+108,090
| New | +$1.17M |
|
2818
Ingevity
NGVT
$2.59B
| $1.18M | ﹤0.01% |
13,530
+1,333
| +11% | +$117K |
|
|
WDR
2819
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $1.18M | ﹤0.01% |
70,672
+2,556
| +4% | +$41.7K |
|
|
FOCS
2820
PUT
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $1.18M | ﹤0.01% |
40,000
-100,000
| -71% | -$2.56M |
|
2821
PUT
Jack in the Box
JACK
$308M
| $1.18M | ﹤0.01% |
+15,100
| New | +$1.25M |
|
2822
United Microelectronic
UMC
$43.6B
| $1.18M | ﹤0.01% |
439,640
-6,276
| -1% | -$15.2K |
|
2823
Solid Biosciences
SLDB
$785M
| $1.18M | ﹤0.01% |
17,634
+12,466
| +241% | +$1.38M |
|
2824
PUT
Under Armour
UAA
$3.04B
| $1.18M | ﹤0.01% |
54,400
-100
| -0.2% | -$1.94K |
|
2825
FerroAtlántica
GSM
$628M
| $1.17M | ﹤0.01% |
1,248,457
-6,478
| -0.5% | -$4.82K |
|
Similar funds
D.E. Shaw & Co's Q4 2019 Portfolio in Review
As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.